Have any questions? 706-721-6582 or cts@augusta.edu
| Study Name | Principal Investigator |
|---|---|
| BP1002-101-Lymph: A Phase 1 Clinical Trial to Study the Safety, Pharmacokinetics, and Efficacy of BP1002 (L-Bcl-2) Antisense Oligonucleotide in Patients with Advanced Lymphoid Malignancies | Bryan, Locke |
RESEARCH. INNOVATION. DISCOVERY.